Seeking Immunity Against COVID-19
Joel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
University of California San Francisco
Give to UCSFJoel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
None of the individual tumor genetic differences that were identified are likely to explain significant differences in health outcomes or to prevent Black Americans from benefiting from a new generation of precision prostate cancer therapies, researchers say, as long as the therapies are applied equitably.
Scientists have developed a prototype tool based on 3D facial imaging that could shorten years undergoing medical tests and waiting for a diagnosis for rare genetic diseases.
An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
BRIDGE is an interface available to physicians during their encounter with patients.
Thousands of UCSF health care workers are mobilizing to prepare for the potential influx of patients sickened by COVID-19, even as hundreds of UCSF scientists race against time to defeat the deadly respiratory virus impacting communities around the world.
UCSF scientists have made a significant advance toward understanding a rare genetic condition, almost exclusively affecting females, that results in a broad spectrum of neurodevelopmental deficits.
The study also identified 12 other FDA-approved drugs that are deemed safe in pregnancy.
UCSF researchers are working on deep-brain stimulation technology that can be customized to the patient’s brain make up and their own brain’s feedback.
Understanding the biological differences that drive distinct symptoms of Alzheimer’s disease could lead to more personalized patient care and potentially therapies targeted to patients’ individual needs.
A low-cost test that screens for excess protein in the urine has been shown to accurately identify patients at higher risk for progressive kidney disease after being hospitalized for acute kidney
Just weeks since the viral illness was first reported in Wuhan, China, health experts globally are working on containing and treating it.To put the latest news in context, we asked UCSF infectious disease expert Charles Chiu, MD, PhD, about the origins of the Wuhan virus and public health risks going forward.
For 15 years, nobody could figure out what was making a young woman so sick. Then neurologist Michael Wilson, MD, tried a radical new test.
In this interview, Keith Yamamoto, PhD, Director of UCSF Precision Medicine, explains why UCSF is considered a leader in the field and describes the "machine" created to fuel new insights and innovation.
UCSF–led research team has discovered the first conclusive evidence that natural selection may also occur at the level of the epigenome and has done so for tens of millions of years.
English and Italian speakers with dementia-related language impairment experience distinct kinds of speech and reading difficulties based on features of their native languages.
A physically and mentally active lifestyle confers resilience to frontotemporal dementia, even in people whose genetic profile makes the eventual development of the disease virtually inevitable.
UCSF postdoctoral researcher for the first time succeeded in keeping a diverse array of glioblastomas alive in the lab using brain organoids
Basic scientist Zena Werb, who has studied cancer cells in UCSF labs for more than four decades, shares her take on the future of cancer medicine.
With the global population of seniors projected to reach 1.5 billion by 2050, it will be more important than ever to reduce the burden of age-related disease. In the future, science will allow us to intervene in the aging process to make this a reality, according to geriatrician John Newman.